Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Essen Biotech
Second Life Therapeutics
Sensei Biotherapeutics, Inc.
Cancer Research UK
NuCana plc
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
OncoC4, Inc.
Kymab Limited
Aminex Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Kineta Inc.
Incyte Corporation
Incyte Corporation
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
FeRx